SightfileU.S. market data from official filings
Companies › PHVS
PHARVARIS N V (PHVS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001830487 · EDGAR filings · Updated 2026-07-15
PHARVARIS N V (PHVS) has reported institutional ownership of 90.4%, with 110 institutional managers holding positions valued at $1.66B per the latest 13F reporting period.
Institutional ownership
90.4%
Institutional managers
110
Reported 13F value
$1.66B
Latest updates
- 2026-07-15 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-13 — Notice of proposed sale filed (Form 144)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-06-30 — Notice of proposed sale filed (Form 144)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PHARVARIS N V has 110 institutional holders and institutional ownership of 90.4%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 13 reporting insiders, with a net reported value of $0.
Related companies
LEGEND BIOTECH CORP (LEGN) · UFP TECHNOLOGIES INC (UFPT) · DR REDDYS LABS LTD (RDY) · AXOGEN INC (AXGN) · NATIONAL HEALTHCARE CORP (NHC) · RAPPORT THERAPEUTICS INC (RAPP)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.